Scholarship 20/11740-9 - Farmacogenética, Epigênese genética - BV FAPESP
Advanced search
Start date
Betweenand

Evaluation of epigenetic mechanisms in response to drug treatments in genes related to Hypertension in an experimental animal model

Grant number: 20/11740-9
Support Opportunities:Scholarships in Brazil - Doctorate (Direct)
Start date until: October 01, 2021
End date until: September 30, 2025
Field of knowledge:Biological Sciences - Pharmacology
Principal Investigator:Riccardo Lacchini
Grantee:Cezar Kayzuka Cotta Filho
Host Institution: Escola de Enfermagem de Ribeirão Preto (EERP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil
Associated scholarship(s):22/07921-3 - Aging-associated Pulmonary Vascular Injury via NOS1/3-mediated oxidative stress, BE.EP.DD

Abstract

It is recent the knowledge that epigenetic reprogramming can occur in adulthood, impacting the course of certain diseases. Key genes play an essential role in the functioning and maintenance of the cardiovascular system, since the deletion of some of them, such as NOS3, which expresses the endothelial Nitric Oxide Synthase (eNOS) gene, responsible for synthesizing most of the Nitric Oxide in vessels, can lead to systemic and pulmonary arterial hypertension, abnormal vascular remodeling, defective and pathological angiogenesis and even defective healing. It has been observed that especially the methylation of the promoter region of genes leads to their "silencing". With these mechanisms in mind, there are drugs that can act to modulate this pathway. Thus, this project aims to evaluate the effects of pharmacological treatments on the regulation of epigenetic mechanisms in specific genes of cardiovascular relevance and inflammatory process in a hypertensive animal model, with two hypotheses: 1) Hypertension will induce changes in the methylation process of specific genes (NOS3, SOCS1, MMPs 2 and 9), changing the gene expression in a time-dependent course, contributing to cardiac morphological and vascular functional changes; 2) the pharmacological treatment (atorvastatin and 5' azacitidine) will modify the methylation framework of the specific genes studied, restoring vascular function and cardiac morphology, decreasing the levels of inflammatory markers in a hypertensive animal model. For this, wistar hannover rats with 2K1C model (Goldblatt model) will be used to induce hypertension. The vascular functioning will be evaluated through aortic vascular reactivity and cardiac morphology to relate them to epigenetic alterations, such as DNA methyltransferase 1 (DNMT 1) activity, methylation of the promoter region of specific genes and gene expression. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
More itemsLess items
Articles published in other media outlets ( ):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
FEREZIN, LETICIA PERTICARRARA; KAYZUKA, CEZAR; PEREIRA, VITORIA CAROLINA RONDON; DE ANDRADE, MURILO FERREIRA; MOLINA, CARLOS AUGUSTO FERNANDES; TUCCI JR, SILVIO; TANUS-SANTOS, JOSE EDUARDO; LACCHINI, RICCARDO. The rs2682826 Polymorphism of the NOS1 Gene Is Associated with the Degree of Disability of Erectile Dysfunction. LIFE-BASEL, v. 13, n. 5, p. 13-pg., . (20/11740-9, 16/04449-0, 18/18312-2)
ALINE ESPOSITO; CEZAR KAYZUKA COTTA FILHO; RICCARDO LACCHINI. Beyond eNOS: Genetic influence in NO pathway affecting drug response. GENETICS AND MOLECULAR BIOLOGY, v. 45, n. 3, . (20/11740-9)
GANTNER, BENJAMIN N.; PALMA, FLAVIO R.; KAYZUKA, CEZAR; LACCHINI, RICCARDO; FOLTZ, DANIEL R.; BACKMAN, VADIM; KELLEHER, NEIL; SHILATIFARD, ALI; BONINI, MARCELO G.. Histone oxidation as a new mechanism of metabolic control over gene expression. TRENDS IN GENETICS, v. 40, n. 9, p. 8-pg., . (20/11740-9, 22/07921-3)

Please report errors in scientific publications list using this form.